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An eleven-year-old spayed female Yorkshire Terrier presented with a sublumbar mass and upon
ultrasonographic examination, was revealed to have a mammary gland tumor. Black to reddish colored
masses, located in the visceral peritoneum of the sublumbar region was observed on laparotomy with
masectomy of the right side. In the laparotomy, we observed reddish masses multifocally located in the
serosal membrane of the large intestine. Histopathologic examination of the intestinal and abdominal
mass showed highly invasiveness into the muscle and metastasis of melanocytic tumor cells through the
blood vessels. The mammary glands showed abnormal hyperplasia of melanocytes, destruction of the
normal glands by tumor cells and infiltration of some lymphocytes in the pool of melanocytic cells. We
have identified a malignant melanoma containing an angiotumoral complex in which tumor cells
occupied a pericytic location along the microvessels with intravasation determined by immuno-
histochemistry for S100 protein and protein kinase C-α. Histologic findings in this dog lead to a diagnosis
of an angiotropic metastatic malignant melanoma.
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Melanoma is relatively common in dogs, accounting for
3% of all neoplasms and up to 7% of all malignant tumors
[1]. Canine malignant melanoma (CMM) is a spontaneous,
aggressive, rare and metastatic neoplasm. CMM of the oral
cavity, nail bed, foot pad and mucocutaneous junction is
a spontaneously occurring, highly aggressive and frequently
metastatic neoplasm [1-4]. Canine oral melanomas are virtually
always considered malignant tumors, whereas more than 95%
of cutaneous melanocytic lesions are benign [5]. Dermal
melanomas in dogs generally follow a benign course. Canine
patients with advanced diseases (WHO stage II, III, or IV)
have reported median survival times of <5 months with
aggressive local excision [1-3]. Unfortunately, response rates
to chemotherapy in dogs with advanced melanoma range
from 8% to 28% with little evidence that treatment improves
survival [6-8]. Therefore, understanding the factors that
contribute to tumor growth and metastatic dissemination is
of paramount importance for the design and effective use
of novel therapeutic strategies to combat tumor growth and
spread. The propensity for malignant melanoma to migrate
along anatomical structures such as nerves (neurotropism)
and skin appendages has been recognized as a common
phenomenon for many years [9].
 The mechanism of melanoma
metastasis in animals is as yet unclear, although previous studies
have reported mechanisms of extravascular migratory
metastasis and anti-tumoral complex [9-13]. To our knowledge,
CMM with metastasis into the internal organs are rare, but
we present an angiotropic metastatic malignant melanoma
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of a dog with detailed histopathological findings using
immunohistochemistry.
Materials and Methods
The masectomized tissue of an 11-year-old female Yorkshire
Terrier with large intestinal and abdominal tissues were
obtained from a Hwanggum Animal Medical Center (Daegu,
Korea) for evaluation of tumors. Radiographs revealed
abdominal masses in the sublumbar region. A laparatomy
revealed masses that were black to reddish colored and 2-
3 mm in diameter; they were multifocally located on the
serosal membrane of the large intestine and visceral
peritoneum of the sublumbar region. The subcutaneous lesion
of the right mammary gland showed a black to reddish mass
with black to reddish petechia and ecchymosis.
Tissues samples for light microscopy were fixed in 10%
neutral buffered formalin, paraffin embedded, and stained
with hematoxylin and eosin (H&E). For immunohistochemistry,
tissue sections were deparaffinized in xylene, rehydrated in
graded alcohol series, incubated in a solution of 0.3% hydrogen
peroxide in methanol for 30 minutes and microwaved at
750 W for 10 min in 10 mmol/L citrate buffer, pH6.0. Tissue
sections were washed with phosphate-buffered saline (PBS)
and then immunostained with primary antibody. The primary
antibodies used recognized S100 protein (diluted in 1:200,
DakoCytomation, Carpinteria, CA, USA), vimentin (diluted
in 1:100, DakoCytomation), protein kinase C-α (PKC-α;
diluted in 1:100, Santa Cruz Biotechnogy, Santa Cruz, CA,
USA). The avidin-biotin-peroxidase complex (ABC) solution
of the ABC kit (Vector Laboratories, Burlingame, CA, USA)
with 3,3-diaminobenzidine (Zymed Laboratories, San Francisco,
CA, USA) was used for detection. Tissue sections were then
rinsed in distilled water and counterstained with Mayer’s
hematoxylin.
Results
The most extensively invaded lesions, skin and mammary
glands showed abnormal hyperplasia of melanocytes in the
dermal layers with hyperactivated epidermis melanocytes
(Figure 1A). Melanocytic tumor cells had invaded into the
dermal lymphatic channels (Figure 1B) and micro vessels and
were hyperpigmented in the dermal reticular layer and deeper
layers. Mammary glands were also heavily pigmented with
mixed round and epithelioid cells. Normal mammary glands
were invaded and destroyed by tumor cells (Figures 1C and
Figure 1. Histopathological findings of the most extensively
invaded lesions, skin and mammary glands. (A) Primary
invasive melanoma. Abnormal hyperplasia of melanocytes in
the dermal layers with hyperactivated epidermis melanocytes.
H&E stain. Scale bar=500 µm. (B) Primary invasive melanoma.
Note melanoma cells closely opposed to the external surface of
microvessel (inset); melanocytic tumor cells invaded into the
dermal lymphatic follicle and are hyperpigmented in the dermal
reticular layer and more deep layers. H&E Stain. Scale bar=200
µm, (inset, H&E stain; Scale bar=500 µm). (C) Mammary glands
also heavily pigmented. Abnormal hyperplasia of melanocytes
as well as invasiveness and destruction of normal mammary
glands by spindle melanocytic tumor cells. H&E stain. Scale
bar=500 µm. (D) Mammary glands also heavily pigmented.
Normal mammary glands were invaded with destruction by
tumor cells. Pleomorphic round cells arranged in sheets or
clusters. H&E stain. Scale bar=200 µm. (E) Malignant melanoma
of the peritoneum lesion. Invasiveness and metastasis of
melanocytic tumor in abdominal connective tissue and blood
vessels. H&E stain. Scale bar=500 µm. (F) Malignant melanoma
of the peritoneum lesion. Epitheloid and fusiform neoplastic
cells infiltration. H&E stain. Scale bar=200 µm. (G and H)
Malignant melanoma of the large intestinal lesion. Invasiveness
into the muscle and metastasis of melanocytic tumor cells
through the blood vessels and lymphatic channels surrounding
glandular ducts. H&E stain. Scale bar=500 µm (G) and 200 µm
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1D). Pleomorphic round cells were arranged in sheets or
clusters. There were also myoepithelial cells exhibiting
hyperplasia. Some lymphocytes had infiltrated the pool of
melanocytic cells. Histologic evaluation of the mass in the
sublumbar region revealed melanocytes intermingled with
abdominal connective tissue and invasiveness of the micro-
vessels (Figures 1E and 1F). The neoplastic cells were fusiform
and epithelioid in the peritoneum. In a section of the large
intestinal mass, melanocytes had invaded the muscular layer
and the metastasis of melanocytic tumor cells through the
blood vessels (Figures 1G and 1H).
Immunohistochemically, mononuclear amelanotic cells
were positive for cytoplasmic vimentin staining (Figure 2A)
and multinucleated cells containing melanin granules were
positive for intranuclear and cytoplasmic S100 staining (Figure
2B). The tumor cells are closely associated with the external
surfaces of microvessels which expressed PKC-α (Figure 2C)
and weakly positive for PKC-ε. Our interpretation of these
observations was that the multifocally invaded tumor, classified
as a malignant melanoma, had at least three distinct lesions
with very similar hyperplasia types and metastasis into blood
vessels.
Discussion
Melanoma may be one of the few neoplasms in animals
whose location is an important prognostic indicator in its
own right [5].
 There is no obvious relationship between
histologic characteristics, including mitotic figures and
pigmentation, and survival rate [4,14]. The initial definitive
diagnosis of melanoma is usually done by histologic evaluation,
with cytopathology used as a screen before biopsy or as an
adjunct to biopsy [15]. Morphology of the melanoma in the
metastatic site is frequently similar to the primary tumor. Distant
sites are sometimes less pigmented and amelanotic epithelioid
in form. Vascular and/or lymphatic invasion has been thought
to be a direct manifestation of metastasis for progress and
prognostic factors. Angiotropism in malignant melanoma has
been observed in previous studies by conventional microscopy
in routine tissue sections in human [13,16-19].
  To our
knowledge, there have been no reports of the origin of the
potential mechanism of melanoma. We evaluated the
expression of vimentin, S100 protein and PKC-α. S100 staining
characteristics have also been useful in the diagnosis of canine
amelanotic melanomas [19,20]. PKC was identified as a
signaling protein involved in the carcinogenesis of skin tumors
[21].
 The  α-isozyme of PKC is widely expressed in tissues
and abnormal levels are found in tissues such as proliferating
pulmonary arteriolar smooth muscle cells and adventitial
fibroblasts after chronic exposure to hypoxia in mammals
[22-26]. In our study, we carefully had to distinguish
angiotropism from entrapment or engulfment of vessels by
the melanoma. PKC-α activation appeared in the epithelium
of microvascular channels and some tumor cells at the
periphery of the vessels. There are a number of known
activation signals for PKC-α such as platelet-derived growth
factor (PDGF), vascular endothelial growth factor (VEGF),
epidermal growth factor (EGF) and fibroblast growth factor
(FGF) [27]. Although the latter feature may in fact constitute
angiotropism and metastasis, we have no means at present
to verify if and when such entrapment is biologically significant.
From our results, there was also vascular/lymphatic invasion,
which has been thought to be a direct manifestation of
metastasis progress. Therefore, we consider the significance
of recording vascular/lymphatic invasion until further studies
are better able to sort out the problems of angiotropism versus
a true intraluminal tumor.
Although our study involved only a single case of melanoma,
it is of interest that the angiotropic melanoma presented had
detailed, interesting findings of histopathology and immuno-
Figure 2. Immunohistochemical stain with antibody for vimentin,
S100 and PKC-α. (A) Malignant melanoma of the skin. Vimentin
expression of mononuclear epitheloid amelanotic melanoma
cells. ABC method, Mayer’s hematoxylin counterstain. Scale
bar=200 µm. (B) Malignant melanoma of the skin. S100 protein
immunoreactivity is detected in melanoma cells, which is
surrounded by multiple S100-negative epitheloid-shaped cells.
ABC method, Mayer’s hematoxylin counterstain. Scale bar=
50 µm. (C) Malignant melanoma of the skin. Immunodetection
of PKC-α in metastatic malignant melanoma. PKC-α expression
in the epithelium of microvessels and some peripheral tumor
cells. ABC method, Mayer’s hematoxylin counterstain. Scale
bar=200 µm.356 Hai Jie Yang et al.
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histochemistry. These results showed that black masses of
the serosal membrane of the large intestine and peritoneum
originated from the skin. The metastasis of most tumors usually
occurs in the lung and other solid organs in clinical cases.
In particular, the serosal membrane and peritoneum are
susceptible to negligible lesion. This report describes the
occurrence of an angiotropic metastatic melanoma in the
serosal membranes of the large intestine rather than the internal
regions of the solid organ.
Acknowledgments
This work was supported by Priority Research Centers
Program through the National Research Foundation of Korea
(NRF) funded by the Ministry of Education, Science and
Technology (2010-0029642) and Basic Science Research
Program through the National Research Foundation of Korea
(NRF) funded by the Ministry of Education, Science and
Technology (2011-0025973) and Hallym Academy of Sciences
at Hallym University in Korea (HRF-2009-039).
References
1. Bostock DE. Prognosis after surgical excision of canine
melanomas. Vet Pathol 1979; 16(1): 32-40.
2. Harvey HJ, MacEwen G., Braun D, Patnaik AK, Withrow SJ,
Jongeward S. Prognostic criteria for dogs with oral
melanoma. J Am Vet Med Assoc 1981; 178(6): 580-582.
3. MacEwen EG, Patnaik AK, Harvey HJ, Hayers AA, Matus R.
Canine oral melanoma: comparison of surgery versus surgery
plus Corynebacterium parvum. Cancer Invest 1986; 4(5):
397-402.
4. Ramos-Vara JA, Beissenherz ME, Miller MA, Johnson GC,
Pace LW, Fard A, Kottler SJ. Reprospective study of 338
canine oral melanomas with clinical, histologic, and
immunohistichemical review of 129 cases. Vet Pathol 2000;
37(6): 597-608.
5. Smith SH, Goldschmidt MH, McManus PM. A comparative
review of melanocytic neoplasms. Vet Pathol 2002; 39(6):
651-678.
6. Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro
AN, Panageas KS, Beqq CB, Aqarwala SS, Schuchter LM,
Ernstoff MS, Houghton AN, Kirkwood JM. Phase III
multicenter randomized trial of the Dartmouth regimen
versus dacarbazine in patients with metastatic melanoma. J
Clin Oncol 1999; 17(9): 2745-2751.
7. Houghton AN, Meyers ML, Chapman PB. Medical treatment
of metastatic melanoma. Surg Clin North Am 1996; 76(6):
1343-1354.
8. Rassinick KM, Ruslander DM, Cotter SM, Al-sarraf R,
Bruyette DS, Gamblin RM, Meleo KA, Moore AS. Use of
carboplatin for treatment of dogs with malignant melanoma:
27 casses (1989-2000). J Am Vet Med Assoc 2001; 218(9):
1444-1448.
9. Barnhill RL. The biology of melanoma micrometastases.
Recent Results Cancer Res 2001; 158: 3-13.
10.Lugassy C, Barnhill RL, Christensen L. Melanoma and
extravascular migratory metastasis. J Cutan Pathol 2000;
27(9): 481.
11.Lugassy C, Eyden BP , Christensen L, Escande JP . Angio-
tumoral complex in human malignant melanoma
characterised by free laminin: ultrastructural and immuno-
histochemical observations. J Submicrosc Cytol Pathol 1997;
29(1): 19-28.
12.Lugassy C, Dickersin GR, Christensen L, Karaoli T,
LeCharpentier M, Escande JP , Barnhill RL. Ultrastructural and
immunohistochemical studies of the periendothelial matrix in
human melanoma: evidence for an amorphous matrix
containing laminin. J Cutan Pathol 1999; 26(2): 78-83.
13.Moreno A, Espanol I, Ramogosa V. Angiotropic malignant
melanoma. Report of two cases. J Cutan Pathol 1992; 19(4):
325-329.
14.Eisen D, Voorhees JJ. Oral melanoma and other pigmented
lesions of the oral cavity. J Am Acad Dermatol 1991; 24(4):
527-537.
15.Griffiths GL, Lumsden JH. Fine neddle aspiration cytology
and histologic correlation in canine tumors. Vet Clin Path
1984; 13(1): 13-17.
16.Kerr S, Going JJ. Angiocentric invasion by lentigo malignat
melanoma. J Clin Pathol 1994; 47(2): 183-184.
17.Shea CR, Kline MA, Lugo J, McNutt NS. Angiotropic
metastatic malignant melanoma. Am J Dermatopathol 1995;
17(1): 58-62.
18.Saluja A, Money N, Zivoney DI, Solomon AR. Angiotropic
malignant melanoma: A rare pattern of local metastases. J
Am Acad Dermatol 2001; 44(5): 829-832.
19.Rabanal RH, Fondevila DM, Montane V, Domingo M, Ferrer
L. Immunocytochemical diagnosis of skin tumours of the dog
with special reference to undifferentiated types. Res Vet Sci
1989; 47(1): 129-133.
20.Sandusky GE Jr, Carlton WW, Wightman KA. Immuno-
histochemial staining for S100 protein in the diagnosis of
canine amelanotic melanoma. Vet Pathol 1985; 22(6): 577-
581.
21.Nishizuka Y. The molecular heterogeneity of protein kinase C
and its implications for cellular regulation. Nature 1988;
334(6184): 661-665.
22.Basu A. The potential of protein kinase C as a target for anti-
cancer treatment. Pharmacol Ther 1993; 59(3): 257-280.
23.Denham DW, Franz MG, Denham W, Zervos EE, Gower WR
Jr, Rosemurgy AS, Norman J. Directed antisense therapy
confirms the role of protein kinase C-α in the tumorigenicity
of pancreatic cancer. Surgery 1998; 124(2): 218-223.
24.Gescher A. Towards selective pharmacological modulation of
protein kinase C-opportunities for the development of novel
anti-neoplastic agents. Br J Cancer 1992; 66(1): 10-19.
25.Cornford P , Evans J, Dodson A, Parsons K, Woolfenden A,
Neoptolemos J, Foster CS. Protein kinase C isoenzyme
patterns characteristically modulated in early prostate cancer.
Am J Pathol 1999; 154(1): 137-144.
26.Tan X, Liu YJ, Li JC, Pan JQ, Sun WD, Wang XL. Activation of
PKCα and pulmonary vascular remodelling in broilers. Res
Vet Sci 2005; 79(2): 131-137.
27.Lahn MM, Sundell KL. The role of protein kinase C-α (PKC-
α) in melanoma. Melanoma Res 2004; 14(2): 85-89.